Vivian Nogueira Silbiger
Overview
Explore the profile of Vivian Nogueira Silbiger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bassani Borges J, Oliveira V, Dagli-Hernandez C, Monteiro Ferreira G, Barbosa T, Marcal E, et al.
Gene
. 2023 May;
875:147501.
PMID: 37217153
Familial hypercholesterolemia (FH) is a monogenic disease characterized by high plasma low-density lipoprotein cholesterol (LDL-c) levels and increased risk of premature atherosclerotic cardiovascular disease. Mutations in FH-related genes account for...
12.
da Silva A, Cruz M, Costa de Souza K, Silbiger V
Mol Biol Rep
. 2023 Jan;
50(3):2835-2845.
PMID: 36596997
Many studies have demonstrated the association of atrial fibrillation (AF) with endogenous genetic regulatory mechanisms. These interactions could advance the understanding of the AF pathophysiological process, supporting the search for...
13.
Duarte V, Cruz M, Bertolami A, Hirata M, Hirata R, Luchessi A, et al.
Sci Rep
. 2022 Nov;
12(1):18612.
PMID: 36329152
TREML4 and other members of the triggering receptor expressed in the myeloid cell family are associated with a risk of atherosclerosis and progression in coronary artery disease, acute coronary syndrome,...
14.
Goes de Araujo J, Oliveira V, Bassani Borges J, Dagli-Hernandez C, Marcal E, Freitas R, et al.
Gene
. 2022 Sep;
849:146908.
PMID: 36167182
Familial hypercholesterolemia (FH) is a prevalent autosomal genetic disease associated with increased risk of early cardiovascular events and death due to chronic exposure to very high levels of low-density lipoprotein...
15.
Medeiros J, de Oliveira Borges M, Soares A, de Sousa E, Ribeiro da Costa J, Silva W, et al.
Int J Sport Nutr Exerc Metab
. 2021 Oct;
32(1):2-7.
PMID: 34689128
Although vitamin D is related to cardiorespiratory fitness and muscle strength, there is no evidence in the literature about the genetic influence of the response to vitamin D supplementation and...
16.
Bertol B, Goes de Araujo J, de Carvalho K, Gonzaga Dos Santos M, Martelli-Palomino G, de Figueiredo Feitosa N, et al.
Arch Med Res
. 2021 Aug;
53(2):163-169.
PMID: 34384609
Background: Interleukin (IL)-17A has a dual role in tumor immunity, promotes anti-tumor responses and facilitates angiogenesis by interacting with IL-17 receptor A (IL-17RA). Although IL-17A has been associated with the...
17.
Ribeiro H, Dantas-Komatsu R, Medeiros J, Carvalho M, Soares V, Reis B, et al.
Clin Chim Acta
. 2021 Aug;
522:8-13.
PMID: 34364853
Background: The relationship of vitamin D status and other biochemical parameters with the risk of SARS-CoV-2 infection remains inconclusive, especially in regions with high solar incidence. Therefore, we aimed to...
18.
Lima-Antoine L, de Sousa Alves Neri J, de Melo T, Leite I, da Costa Santos D, Goes de Araujo J, et al.
Eur J Clin Nutr
. 2021 Jul;
76(3):469-476.
PMID: 34230633
Background/objectives: Experimental and clinical studies have shown that vitamins A and E can inhibit cancer formation and progression. The unfavourable status of these vitamins can represent risk factors for the...
19.
Alves Dos Santos K, Clemente Dos Santos I, Santos Silva C, Ribeiro H, Domingos I, Silbiger V
Int J Mol Sci
. 2021 Jan;
22(1).
PMID: 33396209
Colorectal cancer (CRC) is one of the most common malignant tumors in the gastrointestinal tract. It is a multifactorial disease that involves environmental factors, genetic factors, and lifestyle factors. Due...
20.
Lima S, Martins R, Saldanha V, Silbiger V, Clemente Dos Santos I, de Araujo I, et al.
PLoS One
. 2020 Dec;
15(12):e0243714.
PMID: 33306728
Objective: Development and internal validation of a clinical tool for assessment of the risk of adverse drug reactions (ADR) in hospitalized patients. Methodology: Nested case-control study in an open cohort...